Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ARQT
ELVN
Add up to 3 more stocks
ARQT
Arcutis Biotherapeutics, Inc.
-4.89%
$23.92-1.23Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$2.99B
52W Range
$19.30 - $31.77
ELVN
Enliven Therapeutics, Inc.
-6.77%
$42.39-3.08Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$3.03B
52W Range
$14.79 - $62.32
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 114.72 | N/A |
| Forward P/E | 48.12 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 13.56 | 3.38 |
| P/S Ratio | 6.45 | N/A |
| P/FCF Ratio | 76.42 | N/A |
| EV/EBITDA | 82.57 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 91.1% | 0.0% |
| Operating Margin | -3.3% | 0.0% |
| Net Margin | 6.2% | 0.0% |
| ROE | 12.9% | -11.8% |
| ROA | 5.8% | -11.6% |
| ROIC | 9.9% | -13.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.92 | 64.07 |
| Quick Ratio | 2.67 | 64.07 |
| Debt/Equity | 0.52 | 0.00 |
| Interest Coverage | -1.01 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.